Purification process for large scale production of...

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S414000, C530S416000

Reexamination Certificate

active

06921808

ABSTRACT:
A purification process for large-scale production of Gc-globulin is described. The source of Gc-globulin is preferably a crude plasma fraction but can be any solution, suspension or supernatant containing Gc-globulin, e.g., a milk product, colostrum or a fermentation broth. The Gc-globulin can be plasma-derived or produced by a genetic modified organism. The process includes two key elements: purification by series of ion exchange chromatography steps, and performing at least two virus-reduction steps. A diagnostic method to measure the free Gc-globulin in a patient blood sample, a use of Gc-globulin in medicine and the preparation of a Gc-globulin medicinal product is also provided. The product can be used in therapy for patients with circulatory disorders and complications, i.e., where it is contemplated that patients would benefit from the administration of Gc-globulin.

REFERENCES:
patent: 5326749 (1994-07-01), Yamamoto
patent: WO 91/15770 (1991-10-01), None
patent: WO 96/40903 (1996-12-01), None
patent: WO 97/28688 (1997-08-01), None
E. Cohn et al, “Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids”, J. Am. Chem. Soc., 68:459-475 (Mar., 1946).
N. Cooke et al, “Serum Vitamin D-binding Protein is a Third Member of the Albumin and Alpha Fetoprotein Gene Family”, J. Clin. Invest., 76:2420-2424 (Dec., 1985).
B. Dahl et al, “Serum Gc-globulin in the Early Course of Multiple Trauma”, Crit. Care Med., 26(2):285-289 (1998).
P. Goldschmidt-Clermont et al, “Proportion of Circulating Gc (Vitamin D-Binding Protein) in Complexed Form: Relation to Clinical Outcome in Fulminant Hepatic Necrosis”, Gastroenterology, 94(6):1454-1458 (1988).
F. Wians et al, Immunonephelometric Quantification of Group-Specific Component Protein in Patients with Acute Liver Failure, Liver Transplantation and Surgery, 3(1):28-33 (Jan., 1997).
P. Walsh et al, “‘Rocket’ Immunoelectrophoresis Assay of Vitamin D-Binding Protein (Gc Globulin) in Human Serum”, Clinical Chemistry, 28(8):1781-1783 (1982).
C. Chapuis-Cellier et al, “Interaction of Group-Specific Component (Vitamin D-Binding Protein) with Immobilized Cibacron Blue F3-GA”, Biochimica et Biophysica Acta., 709:353-357 (1982).
R. Bouillon et al, “Serum Vitamin D Metabolites and Their Binding Protein in Patients with Liver Cirrhosis”, J. Clin. Endocrinol. and Metab., 59(1):86-89 (1984).
H. Cleve et al, “Isolation and Partial Characterizatiion of the Two Principal Inherited Group-Specific Components of Human Serum”, J. Exp. Med., 118:711-726 (1963).
F. Schiodt et al, “Admission Levels of Serum Gc-Globulin: Predictive Value in Fulminant Hepatic Failure”, Hepatology, 23:713-718 (1996).
F. Schiodt et al, “Serial Measurements of Serum Gc-Globulin in Acetaminophen Intoxication”, European Journal of Gastroenterology & Hepatology, 7:635-640 (1995).
F. Schiodt et al, “Reduced Serum Gc-Globulin Concentrations in Patients with Fulminant Hepatic Failure: Association with Multiple Organ Failure”, Crit. Care Med., 25(8):1366-1370 (1997).
J. Svasti et al, “Human Group-Specific Component, Changes in Electrtophoretic Mobility Resulting from Vitamin D Binding and from Neuraminidase Digestion”, J. Biol. Chem., 253(12):4188-4194 (Jun., 1978).
N. Swamy et al, “Affinity Purification of Human Plasma Vitamin D-Binding Protein”, Protein Expression and Purification, 6:185-188 (1995).
W. Lee et al, “The Extracellular Actin-Scavenger System and Actin Toxicity”, N. Engl. J. Med., 326(20):1335-1341 (May, 1992).
W. Lee et al, “Predicting Survival in Fulminant Hepatic Failure Using Serum Gc Protein Concentrations”, Hepatology, 21:101-105 (1995).
R. Link et al, “Purification of Human Serum Vitamin D-Binding Protein by 25-Hydroxyvitamin D3-Sepharose Chromatography”, Analytical Biochemistry, 157:262-269 (1986).
L. Miribel et al, “Rapid Purification of Native Group-Specific Component (Vitamin D-Binding Protein) by Differential Affinity for Immobilized Triazine Dyes”, J. Chromatography, 363:448-455 (1986).
S. Dueland et al, “Uptake and Degradation of Filamentous Actin and Vitamin D-Binding Protein in the Rat”, Biochem. J., 274:237-241 (1991).
J. Haddad et al, “25-Hydroxyvitamin D Transport in Human Plasma”, J. Biol. Chem., 251(16):4803-4809 (Aug., 1976).
J. Haddad et al, “Actin Affinity Chromatography in the Purification of Human, Avian and Other Mammalian Plasma Proteins Binding Vitamin D and its Metabolites (Gc Globulins)”, Biochem. J., 218:805-810 (1984).
H. Van Baelen et al, “Vitamin D-Binding Protein (Gc-Globulin) Binds Actin”, J. Biol. Chem., 255(6):2270-2272 (Mar., 1980).
J. Barragry et al, “Plasma Vitamin D-Binding Globulin in Vitamin D Deficiency, Pregnancy and Chronic Liver Disease”, Clinica Chimic Acta., 87:359-365 (1978).
R. Bouillon et al, “The Purification and Characterisation of the Human-Serum Binding Protein for the 25-Hydroxycholecalciferol (Transcalciferin)”, Eur. J. Biochem., 66:285-291 (1976).
G. Taylor et al, “Purification of Vitamin D Binding Protein from Human Plasma Using High Performance Liquid Chromatography”, Clinica Chimica Acta., 155:31-42 (1986).
J.G. Haddad, et al., “Angiopathic consequences of saturating the plasma scavenger system for actin”, Proc. Natl. Acad. Sci. USA, Feb. 1990, pp. 1381-1385, vol. 87.
J.G. Haddad, “Plasma Vitamin D-binding Protein (Gc-globulin): Multiple Tasks”, J. Steroid Biochem. Molec. Biol., 1995, pp. 579-582, vol. 53, Elsevier Science Ltd., Great Britain.
K.D. Harper, et al., “Vitamin D Binding Protein Sequesters Monomeric Actin in the Circulation of the Rat”, J. Clin. Invest., May 1987, pp. 1365-1370, vol. 79, The American Society for Clinical Investigation, Inc.
K. Heide, et al., “Darstellung noch nicht therapeutish angewandter Plasmaproteine”, Berlingwerk Mitteilungen, 1964, pp. 161-193, vol. 43.
M. Kawakami, et al., “Turnover of the Plasma Binding Protein for Vitamin D and Its Metabolites in Normal Human Subjects”, Journal of Clinical Endocrinology and Metabolism, 1981, pp. 1110-1116, vol. 53, No. 6, The Endocrine Society, USA.
P. Kistler, et al., “Large Scale Production of Human Plasma Fractions”, Vox. Sang., 1962, pp. 414-424, vol. 7.
W.M. Lee, et al., “Diminished Serum Gc (Vitamin D-Binding Protein) Levels and Increased Gc:G-Actin Complexes in a Hamster Model of Fulminant Hepatic Necrosis”, Hepatology, 1987, pp. 825-830, vol. 7, No. 5, American Association for the Study of Liver Diseases, USA.
W.M. Lee, et al., “Alterations in Gc Levels and Complexing in Septic Shock”, Circulatory Shock, 1989, pp. 249-255, vol. 28.
A.R. Torres, et al., “Purification of Gc-2 Globulin from Human Serum by Displacement Chromatography: A Model for the Isolation of Marker Proteins Identified by Two-Dimensional Electrophoresis”, Analytical Biochemistry, 1985, pp. 469-476, vol. 144, Academic Press, Inc.
D. Roelcke, et al., “Gc-Darstellung mittels Hydroxylapatit-Säulen-Chromatographie”, Blut, 1967, pp. 331-340, 14.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Purification process for large scale production of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purification process for large scale production of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purification process for large scale production of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3433973

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.